3.8. The MAGL Inhibitor JZL184 Inhibits Tumor Growth in Nude Mice Accompanied by a Reduction in the Angiogenesis Marker CD31 and an Upregulation of the Antiangiogenic Mediator TIMP-1 in the Corresponding Xenografts. Here, MGLL is linked to neoplasm.